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cells were studied at passage 2. Immunohistochemical staining for
alkaline phosphatase, osteocalcin, and collagen I conﬁrmed the
maintenance of osteocytic phenotype. Cells were treated at either
normoxia (20%) or hypoxia (1%) for 2-16 hours. Hypoxia was
achieved with a Biospherix Environmental Chamber. qPCR and
ELISA were done for gene expression and protein concentration
respectively for plasminogen, urokinase and tissue plasminogen
activator (uPA and tPa) and PAI-1. Plasmin activity was assessed
with a functional assay with the speciﬁc substrate S2251.
Results: By two hours of hypoxia, plasmin expression increased
from 4.3±0.4 to 8.9±0.3 (P < 0.001). Plasminogen, uPA and
tPA gene expression increased signiﬁcantly (Fig. 1a, b). However,
PAI-1 gene expression was not increased at any time point (Fig.
2). Protein concentration followed the same pattern at 2-4 hours
of hypoxia (Table 1). PAI-1 protein was not signiﬁcantly increased.
Figure 1. (a) Plasminogen gene experssion. (b) PA gene expression.
Figure 2. PAI 1 gene expression.
Conclusions: Decreased perfusion and hypoxia have been ob-
served both in human and experimental OA bone. This study
demonstrates that hypoxia activates the ﬁbrinolytic pathway in hu-
man OA osteocytes resulting in increased plasmin generation but
reveals a defective response in PAI-1. The lack of PAI-1 expres-
sion in OA osteocytes is at variance with increases in PAI-1 by
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Table 1. Protein Expression
Normoxia Hypoxia P <
Plasminogen 1.5±0.3 2.5±0.3 0.03
uPA 0.3±0.06 1.0±0.3 0.04
tPA 2.5±0.4 6.1±1.4 0.03
PAI-1 15.4±3.7 23.0±4.4 0.20
hypoxia in other tissues such as lung. We suggest that defec-
tive PAI-1 response to hypoxia in OA bone, permitting increased
plasmin generation, is a feature in the pathogenesis of OA and is
associated with an altered physicochemical environment in bone.
If so, this describes a speciﬁc defect that may provide insight into
linkages between physical and chemical pathways that could be
useful in early diagnosis or therapy.
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SHORT-TERM GLUCOCORTICOID TREATMENT ABOLISHED
THE COMBINED CATABOLIC EFFECTS OF TNF-α AND
MECHANICAL INJURY
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Med. Sch., Boston, MA
Purpose: Traumatic joint injury damages cartilage and releases
inﬂammatory cytokines from adjacent joint tissues, increasing the
risk of developing osteoarthritis. Previously, we reported that
mechanical injury increased the catabolic effects of TNF-α in
immature bovine and adult human articular cartilage, and that
endogenous IL-6 played a role in proteoglycan loss caused by
injury+TNF-α treatment. Glucocorticoids such as dexamethasone
can inhibit expression of inﬂammatory genes. In this study we
hypothesized that the combination of mechanical injury and TNF-
α would up-regulate expression of proteins involved in catabolic
and inﬂammatory processes, and that short-term dexamethasone
treatment would prevent cartilage degradation by suppressing the
production of matrix-degrading enzymes and cytokines.
Methods: Cartilage disks (3 mm diam., 1 mm thick) were har-
vested from the middle zone of the femoropatellar grooves of
1-2-week old calves. Location-matched disks were either injuri-
ously compressed (50% strain, 100%/second strain rate) or main-
tained free-swelling, cultured in medium with or without rhTNF-α
(25 ng/ml), and in the presence or absence of dexamethasone
(10nM). Culture was terminated after 6 days of treatment. DMMB
dye was used to quantify sGAG released into the medium. Disks
were radiolabeled during days 4-6 with 5 μCi/ml 35SO-24 and
10 μCi/ml 3H-proline to assess proteoglycan and total protein
synthesis. In parallel tests, cartilage disks from 6 animals were
ﬂash-frozen after 4 days of treatment. RNA was extracted, re-
verse transcribed and the mRNA levels for 24 genes of interest
(proteases, matrix molecules, cytokines, growth and transcription
factors) were measured using qPCR (ABI 7900HT). Within each
condition, RNA copy numbers of each gene were normalized to
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that of 18S from the same condition. To examine the effects
of treatments, each gene was normalized to its level in the no-
treatment control. Statistical analysis was performed using a linear
mixed-effect model, followed by Tukey’s pairwise comparison.
Results: The combination of TNF-α+injury up-regulated the
expression of ADAMTS-4,-5, MMP-3,-9,-13, TIMP-3, iNOS,
Caspase-3 and IL-6 (Fig.1, *p<0.05 vs. no-treatment control).
TNF-α, with or without injury, signiﬁcantly increased GAG loss
(Fig. 2, *p<0.05) and decreased chondrocyte biosynthesis (data
not shown). However, the catabolic effects of TNF-α and TNF-
α+injury were abolished in the presence of dexamethasone: both
proteoglycan loss and biosynthesis remained at the levels similar
to no-treatment controls (Fig. 2).
Figure 2
Conclusions: Mechanical injury potentiated the catabolic re-
sponse induced by TNF-α at the transcript level (data not
shown). Short term glucocorticoid treatment effectively abolished
the catabolic effects of TNF-α plus injury, preventing both proteo-
glycan degradation and biosynthesis reduction. Ongoing studies
focus on identifying the effects of dexamethasone on expression
of inﬂammatory cytokines and enzymes at the transcript level.
Matrix Biochemistry
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PUTATIVE 3D HUMAN TISSUE MODEL FOR
OSTEOARTHRITIS
L. Sun, D.L. Kaplan
Tufts Univ., Medford, MA
Purpose: Osteoarthritis is a major cause of disability during aging.
While the mechanisms involved in osteoarthritis are not yet clear,
animal models and cell lines are most often used as disease mod-
els. However, inherent limitations with these approaches prompt
the need for improved options using human tissue systems. A rel-
evant tissue engineering osteoarthritis model in vitro would allow
more insight into underlying mechanisms and would also provide
a useful platform for drug screening.
Methods: Tissue engineered (TE) cartilage was prepared by using
silk-derived porous 3D scaffolds seeded with primary human chon-
drocytes and culturing in chondrogenic medium for 4 weeks. The
TE cartilage mimicked cartilage in terms of many aspects of cell
and matrix features. An osteoarthritis-like phenotype was induced
by culturing the cells with cytokines, a combination of IL-1β, and
TNF-α, or culturing the cells with conditioned medium from THP-1
derived macrophages. The later served to generate a broad spec-
trum of cytokines to represent the inﬁltration of macrophages in
vivo. The systems were studied for up to 5 weeks in a static culture.
Results: After 1 week with cytokines induction, matrix anabolism-
related genes such as ACAN (GAG) and Col II were dramati-
cally down-regulated; while at the same time genes for matrix
catabolism-related enzymes, such as MMP13, ADAMTS4, were
up-regulated. As a marker of aging and calciﬁcation in osteoarthri-
tis, the Col X gene was up-regulated 7-fold when compared to the
untreated (control) group. The data indicated that chondrocytes
responded to the cytokine stimulation in these 3D cultures and
matrix turnover was initiated, in as a mimic of the disease condi-
tion. After 3 weeks, chondrocyte apoptosis was found in the TE
cartilage, with a higher or dose response effect when the TE carti-
lage system was treated with a higher dose of cytokines. Collagen
type X expression was conﬁrmed by immunohistology. For TE car-
tilage treated with conditioned medium from the macrophages, the
results and trends were similar to those with the cytokine treated
group, except for some differences in magnitude of response in
matrix-related gene expression. This difference may due to the
complex components present in this conditioned media besides
IL-1β and TNF-α.
Conclusions: Silk porous scaffolds provided a compatible envi-
ronment for three-dimensional tissue engineered cartilage. In the
presence of cytokines or conditioned medium from macrophages,
TE cartilage showed osteoarthritis-like phenotypes, with results
generally consistent with previous clinical studies. This approach
may serve as a suitable starting point to generate relevant and
useful in vitro osteoarthritis models.
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ULTRASTRUCTURAL ANALYSIS OF COLLAGEN IN THE
ARTHROPATHY OF ALKAPTONURIA IN VIVO AND IN VITRO
A.M. Taylor, W.D. Fraser, P.J. Wilson, L.R. Ranganath,
J.A. Gallagher
Univ. of Liverpool, Liverpool, United Kingdom
Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condi-
tion resulting from lack of homogentisate 1,2 dioxygenase (HGD),
the enzyme responsible for the breakdown of homogentisic acid
(HGA). HGA accumulates in body tissues resulting in ochronosis,
the deposition of pigmented HGA polymers that have high afﬁnity
for collagenous tissues, primarily articular cartilage of the weight
bearing joints. Over time, pigmentation leads to severe joint de-
generation presenting as osteoarthritis. The aim of this study was
to use light and transmission electron microscopy (TEM) to identify
the location of ochronotic pigment in joint tissues in vivo and in an
in vitro model.
Methods: Tissues were collected at the time of surgery from AKU
patients undergoing joint surgery. C20-A4 transformed human
chondrocytes and SaOS-2 osteosarcoma cells were cultured in
DMEM in the presence or absence of 0.33×10-4 M HGA. All
samples were processed routinely for histology and TEM. Parafﬁn
sections were stained with either H&E or nuclear fast red and
Schmorl’s reagent to highlight pigment. TEM samples were post
stained using uranyl acetate and lead citrate.
Results: Macroscopic examination of AKU tissues revealed in-
tense pigmentation of articular cartilage. Synovial and capsular
tissues had pigmented and non-pigmented areas. Bone was al-
most devoid of pigmentation. H&E staining of surgical tissues
demonstrated pigment intra- and extracellularly. Chondrocytes,
ﬁbroblasts and osteocytes all contained pigment. Ochronotic pig-
ment was located among collagen ﬁbres in articular cartilage,
capsule and synovium. Pigment was absent in mineralised colla-
gen ﬁbres of bone.
Schmorl’s reagent demonstrated smaller amounts of pigment at-
tached to the collagen ﬁbres, undetected using H&E. Schmorl’s
staining of in vitro cultures revealed pigment deposits both intra-
and extracellularly. Ultrastructural examination of tissue samples
revealed pigment deposition on collagen ﬁbres in cartilage and
capsule; in some regions pigment was easily identiﬁable bound to
collagen, whereas others had no pigment. Ultrastructural distribu-
tion differed between capsule and cartilage. Pigment in capsule
was associated with the collagen ﬁbril periodicity and was also
